| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
134.24(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $525.19 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
25,196 |
31,743 |
32,117 |
57,267 |
| Total Sell Value |
$12,607,111 |
$15,766,653 |
$15,943,511 |
$27,492,928 |
| Total People Sold |
4 |
5 |
6 |
7 |
| Total Sell Transactions |
4 |
6 |
8 |
13 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schneider Ryan M. |
Director |
– • – |
2021-07-23 |
4 |
B |
$384.36 |
$499,668 |
D/D |
1,300 |
4,714 |
2.39 |
6% |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2021-07-02 |
4 |
D |
$387.20 |
$2,146,250 |
D/D |
(5,543) |
25,010 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,471 |
|
- |
|
| Tallett Elizebeth E |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,006 |
|
- |
|
| Clark R Kerry |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
7,754 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,955 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,621 |
|
- |
|
| Neri Antonio F |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
3,039 |
|
- |
|
| Jallal Bahija |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
2,902 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
3,414 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,301 |
51,019 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-05-24 |
4 |
AS |
$393.56 |
$18,340,425 |
D/D |
(46,444) |
54,320 |
|
-5% |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-05-24 |
4 |
OE |
$131.80 |
$8,391,369 |
D/D |
46,444 |
100,764 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2021-05-24 |
4 |
AS |
$398.02 |
$520,610 |
D/D |
(1,308) |
9,462 |
|
-5% |
|
| Dixon Robert L Jr |
Director |
– • – |
2021-05-21 |
4 |
S |
$392.87 |
$231,793 |
D/D |
(590) |
8,978 |
|
6% |
|
| Hill Julie A |
Director |
– • – |
2021-05-20 |
4 |
S |
$394.00 |
$515,352 |
D/D |
(1,308) |
31,213 |
|
1% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2021-03-22 |
4 |
AS |
$345.59 |
$20,777,485 |
D/D |
(59,500) |
22,544 |
|
9% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2021-03-22 |
4 |
OE |
$131.80 |
$5,256,579 |
D/D |
38,093 |
82,044 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2021-03-05 |
4 |
S |
$333.94 |
$690,588 |
D/D |
(2,068) |
3,137 |
|
-19% |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2021-03-04 |
4 |
S |
$323.56 |
$21,679 |
D/D |
(67) |
5,205 |
|
-23% |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$13,090 |
D/D |
(42) |
5,272 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2021-03-02 |
4 |
D |
$311.66 |
$512,369 |
D/D |
(1,644) |
100,300 |
|
- |
|
| Patel Prakash R |
EVP & President, DBG |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$171,725 |
D/D |
(551) |
20,737 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$92,251 |
D/D |
(296) |
30,553 |
|
- |
|
| Stark Leah |
EVP & CHRO |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$222,837 |
D/D |
(715) |
12,885 |
|
- |
|
123 Records found
|
|
Page 1 of 5 |
|
|
0.81 (0.15%) 
